Aug 2026· Biotechnology Journal· Vol 21· 0 citations· 44 references
Medicine
TL;DR
A transposase‐mediated platform for stable microRNA (miRNA) expression in CHO cells is established and the first application of a DNA transposon system for long‐term miRNA genome integration is demonstrated, demonstrating the applicability of transposase systems beyond protein‐coding transgenes.
Abstract
Stable expression of regulatory non‐coding RNAs enables targeted cell engineering in Chinese hamster ovary (CHO) cells but commonly relies on random integration, resulting in variable expression. Here, we establish a transposase‐mediated platform for stable microRNA (miRNA) expression in CHO cells and demonstrate the first application of a DNA transposon system for long‐term miRNA genome integration. Using miR‐3096b‐5p, we compared piggyBac‐mediated integration with conventional random integration in antibody‐producing CHO cells. Transposase‐mediated integration enabled rapid generation of stable cell pools with higher fractions of GFP‐expressing cells. Both integration strategies supported comparable growth, viability, and antibody production in batch cultures, indicating that transposase‐mediated miRNA integration does not compromise bioprocess performance. At the molecular level, transposase‐mediated integration resulted in significantly higher transgene copy numbers and markedly increased miRNA expression, translating into stronger and more consistent regulation of the target genes Fuk and Gmds. By combining high integration efficiency and expression stability with the regulatory potential of miRNAs, this approach expands the applicability of transposase systems beyond protein‐coding transgenes and provides a robust platform for precise and durable post‐transcriptional gene regulation in CHO cell engineering.
It is shown that a single transfection of saRNA-encoded jRCaMP1b in hiPSCs generates sustained reporter expression throughout differentiation to 3D cardiac spheroids, allowing the tracking of cardiomyocyte function and drug responses.
Catherine M. Della Santina, Deon S. Ploessl, Nicole Lindsay-Mosher et al.· Cell Reports Methods· 0 citations
An RNA-guided bridge recombinase system is engineered through rational mutagenesis and AI-assisted directed evolution, enabling programmable chromosomal rearrangements in both plant and mammalian cells and achieving up to a 29.8-fold increase in activity.
Rui Gao, Jingjing Wei, Chao Sun et al.· Trends in Biotechnology· 0 citations
Simple Summary Somatic cell reprogramming is an important technology for animal biotechnology, embryo engineering, and genetic improvement. However, the efficiency of reprogramming is limited by epigenetic barriers that restrict the activation of pluripotency-related genes. The long non-coding RNA XIST plays a central...
A virus-like particle (VLP)-based toolkit that delivers diverse CRISPR editing modalities to human monocytes, macrophages and dendritic cells with high efficiency while preserving viability and innate immune responsiveness is presented.
Hyuncheol Jung, Pascal Devant, Carter Ching et al.· Nature Biotechnology· 0 citations
Genome editing in avian systems has largely relied on plasmid-based CRISPR systems and antibiotic selection to achieve successful editing. However, plasmid delivery can result in prolonged nuclease expression and potential unintended DNA integration. In addition, selection-based enrichment may mask the intrinsic geno...
Sydney G. Bingham, Jin Lee Kim, Kiho Lee et al.· Journal of Animal Science· 0 citations
A PepFect14 analog is employed to deliver high-fidelity Cas9-ribonucleoproteins and non-viral repair templates into primary human skin cells to mediate gene editing and repair targeting genes underlying the group of genetic skin blistering disorders epidermolysis bullosa (EB).
Alex du Rand, Courtney Masterson, Daniel J. Verdon et al.· Bioengineering & Translation...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.